Table 1

Demographic characteristics and baseline variables

Examination cohort
(n=3157 with 23 987 visits)
Validation cohort
(n=3154 with 24 160 visits)
P values
Age (years), mean (SD)52.0 (13.8)52.0 (13.8)0.96
Female, n (%)1746 (55.3)1686 (53.5)0.14
66 swollen joint count, mean (SD)/median (25th,75th percentile)2.3 (4.1)/0 (0,3) (n=1449)2.4 (4.4)/0 (0,3) (n=1450)0.55
28 swollen joint count, mean (SD)/median (25th, 75th percentile)1.3 (2.5)/0 (0,2) (n=3157)1.3 (2.4)/0 (0,2) (n=3154)0.53
68 tender joint count, mean (SD)/median (25th, 75th percentile)6.7 (9.2)/3 (0,9) (n=1510)6.8 (9.3)/4 (0,9) (n=1506)0.42
28 tender joint count, mean (SD)/median (25th, 75th percentile)3.4 (5.2)/1 (0,5) (n=3157)3.3 (5.0)/1 (0,4) (n=3154)0.45
Patient’s global, 0–100 VAS scale, mean (SD)/median (25th, 75th percentile)46.4 (29.6)/48 (20, 71) (n=2732)45.9 (29.0)/46 (20, 70) (n=2728)0.53
Evaluator’s global, 0–100 VAS scale, mean (SD)/median (25th, 75th percentile)16.7 (15.8)/12 (5, 24) (n=2792)16.8 (15.6)/12 (5, 24) (n=2806)0.83
Patient’s pain, 0–100 VAS scale, mean (SD)/median (25th, 75th percentile)41.0 (26.9)/ 38 (19, 63) (n=2664)40.3 (26.4)/ 37 (18, 61) (n=2670)0.68
CRP, mg/L, mean (SD)/ median (25th,75th percentile)8.6 (16.0)/4 (2, 9) (n=2780)8.4 (13.0)/4 (2, 10) (n=2754)0.73
SDAI, mean (SD)/median (25th, 75th percentile)11.9 (9.9)/9.4 (4.5, 16.3) (n=2200)11.5 (9.7)/9 (2, 16) (n=2189)0.22
CDAI, mean (SD)/median (25th, 75th percentile)11.0 (9.5)/8.7 (4.0, 15.3) (n=2427)10.7 (9.2)/8.3 (4.0, 14.9) (n=2436)0.33
DAS28CRP, mean (SD)/median (25th, 75th percentile)3.1 (1.3)/3.0 (2.1, 4.0) (n=2483)3.1 (1.3)/2.9 (2.1, 4.0) (n=2455)0.16
HAQ, mean (SD)/median (25th, 75th percentile)0.7 (0.6)/0.6 (0.1, 1.1) (n=2610)0.7 (0.6)/0.6 (0.1, 1.0) (n=2593)0.30
  • CDAI, clinical disease activity index; CRP, C reactive protein; DAS28CRP, 28-joint disease activity score with CRP; HAQ, Health Assessment Questionnaire; SDAI, simplified disease activity index; VAS, visual analogue scale.